New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
07:15 EDTBDSIBioDelivery Sciences randomized half the patients required for Clonidine study
BioDelivery Sciences International announced that it has randomized more than half of the planned number of patients required for its ongoing initial Phase 3 study of Clonidine Topical Gel, BDSI's proposed treatment for painful diabetic neuropathy. The intent of the study will be to demonstrate the efficacy and safety of Clonidine Topical Gel for the treatment of PDN. An interim analysis of the study, which will be based on the first 50% of patients entering the study, is now anticipated to occur in the Q3 of 2014. It was earlier projected based on estimated patient enrollment the interim analysis would occur in fourth quarter of this year. The purpose of the interim analysis is to confirm the assumptions regarding the study sample size and allow for an increase if needed.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:37 EDTBDSIActive equity options trading on open
Subscribe for More Information
March 26, 2015
13:46 EDTBDSIBioDelivery Sciences volatility elevated
BioDelivery Sciences April call option implied volatility is at 126, May is at 101, June is at 82; compared to its 26-week average of 78 according to Track Data, suggesting large near term price movement.
March 20, 2015
15:16 EDTBDSIBioDelivery Sciences April volatility elevated
Subscribe for More Information
March 17, 2015
09:25 EDTBDSIOn The Fly: Pre-market Movers
Subscribe for More Information
March 16, 2015
19:00 EDTBDSIOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTBDSIBioDelivery Sciences reports Q4 EPS (51c), consensus (33c)
Subscribe for More Information
March 13, 2015
11:37 EDTBDSIBioDelivery Sciences volatility elevated into Q4 and outlook
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use